
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8375166
[patent_doc_number] => 08257956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Sulfonylurea-responsive repressor proteins'
[patent_app_type] => utility
[patent_app_number] => 12/603739
[patent_app_country] => US
[patent_app_date] => 2009-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 49856
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12603739
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/603739 | Sulfonylurea-responsive repressor proteins | Oct 21, 2009 | Issued |
Array
(
[id] => 6481148
[patent_doc_number] => 20100041868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Conserved neisserial antigens'
[patent_app_type] => utility
[patent_app_number] => 12/589218
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 22009
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041868.pdf
[firstpage_image] =>[orig_patent_app_number] => 12589218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/589218 | Conserved Neisserial antigens | Oct 18, 2009 | Issued |
Array
(
[id] => 6220035
[patent_doc_number] => 20100055130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/573929
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20669
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573929
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573929 | Staphylococcus aureus proteins and nucleic acids | Oct 5, 2009 | Issued |
Array
(
[id] => 5958542
[patent_doc_number] => 20110182929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'MULTICOMPONENT VACCINE FOR MALARIA PROVIDING LONG-LASTING IMMUNE RESPONSES AGAINST PLASMODIA'
[patent_app_type] => utility
[patent_app_number] => 13/121574
[patent_app_country] => US
[patent_app_date] => 2009-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14474
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182929.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121574
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121574 | Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia | Sep 30, 2009 | Issued |
Array
(
[id] => 6245690
[patent_doc_number] => 20100136014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein'
[patent_app_type] => utility
[patent_app_number] => 12/571363
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12506
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136014.pdf
[firstpage_image] =>[orig_patent_app_number] => 12571363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/571363 | GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein | Sep 29, 2009 | Abandoned |
Array
(
[id] => 6544128
[patent_doc_number] => 20100016234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'SIGNAL PEPTIDES, NUCLEIC ACID MOLECULES AND METHODS FOR TREATMENT OF CARIES'
[patent_app_type] => utility
[patent_app_number] => 12/563585
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16106
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016234.pdf
[firstpage_image] =>[orig_patent_app_number] => 12563585
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/563585 | SIGNAL PEPTIDES, NUCLEIC ACID MOLECULES AND METHODS FOR TREATMENT OF CARIES | Sep 20, 2009 | Abandoned |
Array
(
[id] => 6614463
[patent_doc_number] => 20100099617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 12/585371
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48868
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099617.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585371
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585371 | Secreted proteins | Sep 13, 2009 | Issued |
Array
(
[id] => 9112563
[patent_doc_number] => 08568731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Staphylococcus aureus antigenic polypeptides and compositions'
[patent_app_type] => utility
[patent_app_number] => 12/555626
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5503
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555626
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555626 | Staphylococcus aureus antigenic polypeptides and compositions | Sep 7, 2009 | Issued |
Array
(
[id] => 6024927
[patent_doc_number] => 20110053253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'MICROORGANISM PRODUCING O-ACETYL-HOMOSERINE AND THE METHOD OF PRODUCING O-ACETYL-HOMOSERINE USING THE MICROORGANISM'
[patent_app_type] => utility
[patent_app_number] => 12/550121
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6914
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053253.pdf
[firstpage_image] =>[orig_patent_app_number] => 12550121
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550121 | Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism | Aug 27, 2009 | Issued |
Array
(
[id] => 5958594
[patent_doc_number] => 20110182981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'GONOCOCCAL VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/060309
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18087
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182981.pdf
[firstpage_image] =>[orig_patent_app_number] => 13060309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060309 | GONOCOCCAL VACCINES | Aug 23, 2009 | Abandoned |
Array
(
[id] => 6222457
[patent_doc_number] => 20100056447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE'
[patent_app_type] => utility
[patent_app_number] => 12/543535
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 170
[patent_figures_cnt] => 170
[patent_no_of_words] => 79967
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12543535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543535 | IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE | Aug 18, 2009 | Abandoned |
Array
(
[id] => 6254755
[patent_doc_number] => 20100028945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID SEQUENCES ENCODING STRESS-RELATED PROTEINS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/543838
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 67788
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028945.pdf
[firstpage_image] =>[orig_patent_app_number] => 12543838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543838 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID SEQUENCES ENCODING STRESS-RELATED PROTEINS AND USES THEREFOR | Aug 18, 2009 | Abandoned |
Array
(
[id] => 7807541
[patent_doc_number] => 20120058495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'Recombinant fragments and synthetic peptides of 17-kDa polypeptide useful in detecting Bartonella henselae'
[patent_app_type] => utility
[patent_app_number] => 12/462602
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 14261
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058495.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462602
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462602 | Recombinant fragments and synthetic peptides of 17-kDa polypeptide useful in detecting Bartonella henselae | Aug 5, 2009 | Issued |
Array
(
[id] => 6164907
[patent_doc_number] => 20110195075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'USE OF A PNEUMOCOCCAL P4 PEPTIDE FOR ENHANCING OPSONOPHAGOCYTOSIS IN RESPONSE TO A PATHOGEN'
[patent_app_type] => utility
[patent_app_number] => 13/056522
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21674
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195075.pdf
[firstpage_image] =>[orig_patent_app_number] => 13056522
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056522 | Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen | Jul 30, 2009 | Issued |
Array
(
[id] => 8269945
[patent_doc_number] => 08211447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Recombinant P. falciparum merozoite protein-142 vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/507004
[patent_app_country] => US
[patent_app_date] => 2009-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 16902
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12507004
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/507004 | Recombinant P. falciparum merozoite protein-142 vaccine | Jul 20, 2009 | Issued |
Array
(
[id] => 8712857
[patent_doc_number] => 08398996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Staphylococcus aureus proteins and nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 12/460422
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20710
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12460422
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460422 | Staphylococcus aureus proteins and nucleic acids | Jul 16, 2009 | Issued |
Array
(
[id] => 6102105
[patent_doc_number] => 20110165597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => ' METHOD FOR THE SCREENING OF CONSERVED SECRETED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/002446
[patent_app_country] => US
[patent_app_date] => 2009-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12316
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165597.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002446
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002446 | Method for the screening of conserved secreted proteins | Jul 2, 2009 | Issued |
Array
(
[id] => 7511373
[patent_doc_number] => 20110257083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'MSP-1 PROTEIN PREPARATIONS FROM PLASMODIUM'
[patent_app_type] => utility
[patent_app_number] => 13/001020
[patent_app_country] => US
[patent_app_date] => 2009-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14234
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257083.pdf
[firstpage_image] =>[orig_patent_app_number] => 13001020
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001020 | MSP-1 PROTEIN PREPARATIONS FROM PLASMODIUM | Jul 2, 2009 | Abandoned |
Array
(
[id] => 6483075
[patent_doc_number] => 20100008924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'FUSION PROTEINS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF LEISHMANIASIS'
[patent_app_type] => utility
[patent_app_number] => 12/497178
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20492
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008924.pdf
[firstpage_image] =>[orig_patent_app_number] => 12497178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/497178 | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis | Jul 1, 2009 | Issued |
Array
(
[id] => 7731664
[patent_doc_number] => 20120015000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'MALARIA VACCINE OF SELF-ASSEMBLING POLYPEPTIDE NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/056298
[patent_app_country] => US
[patent_app_date] => 2009-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22855
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015000.pdf
[firstpage_image] =>[orig_patent_app_number] => 13056298
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056298 | MALARIA VACCINE OF SELF-ASSEMBLING POLYPEPTIDE NANOPARTICLES | Jun 28, 2009 | Abandoned |